The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Regulatory News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.715
Bid: 0.65
Ask: 0.70
Change: 0.09 (14.40%)
Spread: 0.05 (7.692%)
Open: 0.625
High: 0.715
Low: 0.715
Prev. Close: 0.625
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment

22 Mar 2016 16:14

RNS Number : 9481S
Onzima Ventures PLC
22 March 2016
 

22 March 2016

 

Onzima Ventures PLC

 

("Onzima" or the "Company")

 

Investment

 

The Company announces that it has participated in the placing of new ordinary shares by Jubilee Platinum plc ("Jubilee") as announced today as part of a total fundraise of £2.5 million gross.

 

Jubilee has also today announced the successful completion of debt project funding for the execution and commissioning of both of its two surface platinum processing projects at Dilokong and Hernic in South Africa. The debt funding comprises a combination of senior secured debt to a maximum of USD 10 million (ZAR 153 million) and unsecured debt to a maximum of USD 5 million (ZAR 76.5 million). The total funding allows Jubilee to execute simultaneously its two projects targeting the processing of 80,000 tonnes per month of surface material, while still being able to pursue the acquisition or securing of further surface or shallow platinum bearing opportunities.

 

Onzima subscribed for 4.7million shares at 2.8p per share for a total sum of approximately £132,000.

 

Luke Cairns, Director of Onzima, stated: "We are pleased to have taken part in this fundraising at what we consider is an attractive price. Jubilee is at a transformational stage as it looks to move into production at both of its new platinum tailings operations, while its Tjate mine project progresses in the background. Jubilee expects both Dilokong and Hernic to be producing this year thus we anticipate plenty of positive newsflow in the short term."

 

 

For further information please contact:

 

Onzima Ventures PLC Tel: +44 (0) 1732 366561

Gavin Burnell, Luke Cairns

 

Nominated Adviser

Cairn Financial Advisers LLP Tel: +44 (0) 20 7148 7900

Sandy Jamieson, Liam Murray

 

Broker

Peterhouse Corporate Finance Limited Tel: +44 (0) 20 7469 0930

Guy Miller, Lucy Williams

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAKDAAFDKEFF
Date   Source Headline
16th Mar 202010:26 amRNSHolding(s) in Company
4th Mar 20207:00 amRNSPosting of Annual Report and Notice of AGM
25th Feb 20207:00 amRNSFinal Results
11th Feb 20207:00 amRNSResearch Collaboration Agreement
29th Jan 20207:00 amRNSUpdate on Nuvec® process improvements
18th Sep 20197:00 amRNSInterim Results
20th Aug 20197:00 amRNSResults of University of Queensland Study
13th Aug 201911:16 amRNSHolding(s) in Company
15th Jul 20192:05 pmRNSSecond Price Monitoring Extn
15th Jul 20192:00 pmRNSPrice Monitoring Extension
3rd Jul 20194:40 pmRNSSecond Price Monitoring Extn
3rd Jul 20194:35 pmRNSPrice Monitoring Extension
19th Jun 201912:51 pmRNSResult of AGM
19th Jun 20197:00 amRNSAGM Statement
14th Jun 20194:41 pmRNSSecond Price Monitoring Extn
14th Jun 20194:36 pmRNSPrice Monitoring Extension
28th May 20192:21 pmRNSChange to Director Shareholding
22nd May 20197:00 amRNSPosting of Annual Report and Notice of AGM
21st May 20197:00 amRNSBoard Changes
14th May 20197:00 amRNSFinal Results
15th Apr 20197:00 amRNSNuvec® Research update
10th Apr 201911:52 amRNSDirector/PDMR Shareholding
9th Apr 20197:00 amRNSNuvec® Research update
20th Mar 20199:40 amRNSHolding(s) in Company
20th Mar 20199:40 amRNSHolding(s) in Company
28th Feb 20195:00 pmRNSTotal Voting Rights
14th Feb 20192:14 pmRNSHolding(s) in Company
8th Feb 201912:23 pmRNSPlacing to raise £1.05 million
20th Dec 20187:00 amRNSNuvec licence extension
28th Nov 20187:00 amRNSNuvec® research update
16th Nov 20181:36 pmRNSNuvec resource changes
15th Nov 20187:00 amRNSFiling of further Nuvec® patent application
14th Nov 201811:05 amRNSSecond Price Monitoring Extn
14th Nov 201811:00 amRNSPrice Monitoring Extension
14th Nov 20189:05 amRNSSecond Price Monitoring Extn
14th Nov 20189:00 amRNSPrice Monitoring Extension
8th Nov 20184:40 pmRNSSecond Price Monitoring Extn
8th Nov 20184:35 pmRNSPrice Monitoring Extension
8th Nov 20182:05 pmRNSSecond Price Monitoring Extn
8th Nov 20182:00 pmRNSPrice Monitoring Extension
5th Nov 201811:06 amRNSSecond Price Monitoring Extn
5th Nov 201811:00 amRNSPrice Monitoring Extension
5th Nov 20189:00 amRNSPrice Monitoring Extension
5th Nov 20187:54 amRNSResearch collaboration update
29th Oct 20187:00 amRNSNuvec® research update
2nd Oct 201811:44 amRNSResearch collaboration for novel DNA vaccine
26th Sep 20181:48 pmRNSGrant of options
26th Sep 201811:00 amRNSPrice Monitoring Extension
24th Sep 20184:41 pmRNSSecond Price Monitoring Extn
24th Sep 20184:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.